Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Free Cash Flow: -100.04M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.04M |
| September 30, 2023 | -106.43M |
| June 30, 2023 | -101.70M |
| March 31, 2023 | -96.38M |
| December 31, 2022 | -91.75M |
| September 30, 2022 | -91.14M |
| June 30, 2022 | -88.09M |
| Date | Value |
|---|---|
| March 31, 2022 | -81.49M |
| December 31, 2021 | -71.83M |
| September 30, 2021 | -62.32M |
| June 30, 2021 | -52.90M |
| March 31, 2021 | -41.22M |
| December 31, 2020 | -30.48M |
Free Cash Flow Range, Past 5 Years
-106.43M
Minimum
Sep 2023
-30.48M
Maximum
Dec 2020
-78.14M
Average
-88.09M
Median
Jun 2022
Free Cash Flow Benchmarks
| XOMA Corp | -18.20M |
| Societal CDMO Inc (DELISTED) | -9.242M |
| NGM Biopharmaceuticals Inc (DELISTED) | -133.45M |
| Avrobio Inc | -50.48M |
| Landos Biopharma Inc | -20.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.36M |
| Cash from Investing (Quarterly) | 22.70M |
| Free Cash Flow Per Share (Quarterly) | -0.3685 |
| Free Cash Flow Yield | -81.06% |